Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0093 Transporter Info | ||||
Gene Name | SLC13A3 | ||||
Transporter Name | Sodium/dicarboxylate cotransporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg16131972) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.87E+00 | Statistic Test | p-value: 1.62E-06; Z-score: 1.34E+00 | ||
Methylation in Case |
4.49E-01 (Median) | Methylation in Control | 2.40E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC13A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (ch.20.983686F) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.41E-05; Z-score: -8.98E-01 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A3 in breast cancer | [ 2 ] | |||
Location |
5'UTR (ch.20.983686F) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.42E+00 | Statistic Test | p-value: 1.64E-06; Z-score: -9.03E-01 | ||
Methylation in Case |
6.51E-02 (Median) | Methylation in Control | 9.22E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A3 in colorectal cancer | [ 3 ] | |||
Location |
5'UTR (cg16131972) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.05E-02; Z-score: -3.40E-01 | ||
Methylation in Case |
9.45E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A3 in papillary thyroid cancer | [ 4 ] | |||
Location |
5'UTR (ch.20.983686F) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.80E-04; Z-score: -7.11E-01 | ||
Methylation in Case |
6.85E-02 (Median) | Methylation in Control | 7.66E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC13A3 in pancretic ductal adenocarcinoma | [ 5 ] | |||
Location |
1stExon (cg10141715) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 7.24E-13; Z-score: 2.13E+00 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 3.44E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC13A3 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.28E-08; Fold-change: -0.230671232; Z-score: -19.78153537 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.